New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

S Apostolakis, E Shantsila, Gregory Lip

Research output: Contribution to journal › Article

3 Citations (Scopus)

Original language	English
Pages (from-to)	793-5
Number of pages	3
Journal	PharmacoEconomics
Volume	27
Issue number	10
DOIs	https://doi.org/10.2165/11313780-000000000-00000
Publication status	Published - 1 Jan 2009

Keywords

thromboembolism
antiplatelet agents
heart failure
antithrombotic therapy

Access to Document

10.2165/11313780-000000000-00000

Cite this

@article{c470996081d84efeb7030570e7b1e13c,

title = "New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?",

keywords = "thromboembolism, antiplatelet agents, heart failure, antithrombotic therapy",

author = "S Apostolakis and E Shantsila and Gregory Lip",

year = "2009",

month = jan,

day = "1",

doi = "10.2165/11313780-000000000-00000",

language = "English",

volume = "27",

pages = "793--5",

journal = "PharmacoEconomics",

publisher = "Springer",

number = "10",

}

TY - JOUR

T1 - New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?

AU - Apostolakis, S

AU - Shantsila, E

AU - Lip, Gregory

PY - 2009/1/1

Y1 - 2009/1/1

KW - thromboembolism

KW - antiplatelet agents

KW - heart failure

KW - antithrombotic therapy

U2 - 10.2165/11313780-000000000-00000

DO - 10.2165/11313780-000000000-00000

M3 - Article

C2 - 19803535

VL - 27

SP - 793

EP - 795

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 10

ER -